Pharmaceuticals

What Is The Forecast Valuation Of The Fetal Bovine Serum Market Projected To Reach $1.31 Billion By 2029?

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Fetal Bovine Serum Market?

The market size of fetal bovine serum has been experiencing consistent growth in the past few years. Its value is projected to increase from $1.02 billion in 2024 to $1.06 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.6%. The prior growth period was primarily driven by the expansion of the biopharmaceutical industry, an increase in cell-based therapies, and the need for quality and consistency.

Expectations point towards a robust expansion in the fetal bovine serum market size in the approaching years. The market is projected to reach “$1.31 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 5.4%. This anticipated growth in the forecast period is partly due to the rise in the adoption of cell therapies, the development of advanced therapeutics, attention towards animal-free alternatives, and strategic relationships between suppliers and customers. Important trends expected within the forecast period are an emphasis on quality and traceability, international collaborations and partnerships, strategic mergers and acquisitions, tailored fetal bovine serum products, as well as regulatory compliance and ethical sourcing.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp

What Underlying Factors Are Supporting The Fetal Bovine Serum Market Growth?

Anticipated market expansion of fetal bovine serum is being fueled by the rising demand for biopharmaceuticals. Biopharmaceuticals are medical products originating from biological sources such as animals, humans, and microorganisms, manufactured using biotechnological methods. Fetal bovine serum (FBS) is an extensively used replacement for animal cell culture media. Biologics research heavily relies on FBS for cell culture necessities, particularly within pharmaceutical companies, diagnostic laboratories, and among researchers. In 2022, a lifesciences service and consulting firm based in the UK, ProClinical Limited, reported an 11% YOY increase in its pharmaceuticals and vaccines segments, totaling up to US$36.15mn. This increasing requirement for biopharmaceuticals stimulates the growth of the fetal bovine serum market.

How Is The Fetal Bovine Serum Market Segmented Across Key Categories?

The fetal bovine serum market covered in this report is segmented –

1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products

2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human And Animal Vaccine Production, Diagnostics, Other Applications

3) By End-User: Research And Academic Institutes, Biotechnology And Pharmaceutical Industry, Other End-Users

Subsegments:

1) By Charcoal Stripped: Standard Charcoal Stripped FBS, Heat-Inactivated Charcoal Stripped FBS

2) By Chromatographic: Ion Exchange Chromatography Purified FBS, Affinity Chromatography Purified FBS

3) By Dialyzed Fetal Bovine Serum: Standard Dialyzed FBS, Heat-Inactivated Dialyzed FBS

4) By Exosome Depleted: Standard Exosome Depleted FBS, Heat-Inactivated Exosome Depleted FBS

5) By Stem Cell: Stem Cell Grade FBS, Knockout Serum Replacement

6) By Other Products: Serum from Specific Animal Breeds, Custom-Processed FBS

What Key Trends Are Driving Growth In The Fetal Bovine Serum Market?

The emerging trend in the fetal bovine serum market is characterized by heightened alliances between corporations and research institutes. Major firms are joining forces to enhance production capacity, increase market penetration, and facilitate product innovation. For example, GE Healthcare, a US company, partnered with Oritain, a New Zealand firm, to create an independent test capable of verifying the country of origin of fetal bovine serum (FBS). This is beneficial to biomanufacturing companies as FBS sourced from various countries presents varied levels of virus contamination risk.

Which Companies Are Contributing Significantly To The Fetal Bovine Serum Market Growth?

Major companies operating in the fetal bovine serum market include Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report

Which Region Dominates The Fetal Bovine Serum Market Today?

North America was the largest region in the fetal bovine serum market in 2024. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=4109&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model